Mark Sheptoff Financial Planning, LLC Regenxbio Inc. Transaction History

Mark Sheptoff Financial Planning, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$33.61 - $49.95 $10,083 - $14,985	-300 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$65.0 - $82.15 $663,000 - $837,930	-10,200 Reduced 97.14%	300 $23,000
Q2 2018 Aug 09, 2018	BUY	$27.2 - $74.35 $285,600 - $780,674	10,500 New	10,500 $753,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.